Market Cap | 561.11M | P/E | - | EPS this Y | 7.30% | Ern Qtrly Grth | - |
Income | -352.46M | Forward P/E | -2.82 | EPS next Y | 34.20% | 50D Avg Chg | 8.00% |
Sales | 1.46B | PEG | -1.02 | EPS past 5Y | 12.03% | 200D Avg Chg | 80.00% |
Dividend | 2.00% | Price/Book | 0.22 | EPS next 5Y | 3.20% | 52W High Chg | -29.00% |
Recommedations | 3.00 | Quick Ratio | 14.30 | Shares Outstanding | 240.58M | 52W Low Chg | 284.00% |
Insider Own | 10.27% | ROA | -0.87% | Shares Float | 172.18M | Beta | 2.21 |
Inst Own | 74.74% | ROE | -15.13% | Shares Shorted/Prior | 7.67M/8.17M | Price | 2.34 |
Gross Margin | 16.44% | Profit Margin | -24.14% | Avg. Volume | 3,603,053 | Target Price | 4.00 |
Oper. Margin | -2.46% | Earnings Date | Oct 30 | Volume | 1,756,764 | Change | 10.38% |
DHC is a real estate investment trust, or REIT, focused on owning high-quality healthcare properties located throughout the United States. DHC seeks diversification across the health services spectrum by care delivery and practice type, by scientific research disciplines and by property type and location. As of December 31, 2023, DHC's approximately $7.2 billion portfolio included 371 properties in 36 states and Washington, D.C., occupied by approximately 500 tenants, and totaling approximately 8.6 million square feet of life science and medical office properties and more than 27,000 senior living units. DHC is managed by The RMR Group (Nasdaq: RMR), a leading U.S. alternative asset management company with over $41 billion in assets under management as of December 31, 2023 and more than 35 years of institutional experience in buying, selling, financing and operating commercial real estate. DHC is headquartered in Newton, MA.
JMP Securities | Market Perform | Aug 21, 24 |
B. Riley Securities | Buy | Aug 5, 24 |
B. Riley Securities | Buy | Sep 5, 23 |
B. Riley Securities | Buy | Dec 30, 21 |
Morgan Stanley | Equal-Weight | Jul 29, 21 |
Morgan Stanley | Equal-Weight | Mar 15, 21 |
Morgan Stanley | Equal-Weight | Feb 2, 21 |
B of A Securities | Underperform | Nov 16, 20 |
Morgan Stanley | Equal-Weight | Oct 9, 20 |